LYNPARZA (olaparib) Receives Positive EU CHMP Opinion For Use in Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer
KENILWORTH, N.J.--(BUSINESS WIRE)--Mar 1, 2019--AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicina…
